A single site study to investigate the current prevalence of anti‐hepatitis C virus antibody among substance use disorder patients in Hiroshima—Insufficient testing and diagnosis

A single site study to investigate the current prevalence of anti‐hepatitis C virus antibody among substance use disorder patients in Hiroshima—Insufficient testing and diagnosis

Abstract Aims Hepatitis C virus (HCV) infection among drug users presents an important public health problem; however, little recognition and few approaches to address this issue in Japan. This study was conducted to investigate the current disease status by assessing anti‐HCV antibody (Ab) seroprev...

Full description

Bibliographic Details
Main Authors: Ariyuki Kagaya, Yuko Nagaoki, Satomi Shimura, Katsuyoshi Kawana, Kazuaki Chayama
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Neuropsychopharmacology Reports
Subjects:
harm reduction
HCV seroprevalence
hepatitis C virus
people who inject drugs
people who use drugs
Online Access:https://doi.org/10.1002/npr2.12346

Internet

https://doi.org/10.1002/npr2.12346

Similar Items